About Prof. Li Hengyu
Prof. Li Hengyu (李恒宇) is a Chief Physician, Professor, Medical Doctor, and Master's Supervisor, and serves as the Director of the Department of Thyroid and Breast Surgery at Changhai Hospital (First Affiliated Hospital of Naval Medical University) in Shanghai. With over 20 years of dedicated clinical practice in thyroid and breast surgery, Prof. Li is one of Shanghai's most experienced and technically accomplished surgeons in this specialty.
Prof. Li's surgical philosophy centers on precision, minimal trauma, and rapid recovery. He has been invited multiple times to perform live surgical demonstrations and has served as a judge in surgical skills competitions. In 2024, he was selected for Changhai Hospital's prestigious "Changjian" Leadership Talent Development Program, and he has received the Shanghai Science and Technology Popularization Second Prize. He holds membership in the Breast Tumor Group of the Oncology Branch of the Chinese Medical Association and the Breast Cancer Expert Committee of CSCO, and has participated in developing multiple Chinese expert consensus documents and clinical guidelines.
Clinical Expertise
- Breast cancer surgery and comprehensive treatment — breast-conserving surgery, mastectomy, sentinel lymph node biopsy, and axillary dissection; integration with chemotherapy, radiation, targeted therapy, and immunotherapy
- Advanced breast cancer — targeted and immunotherapy — systemic treatment planning for HER2-positive, triple-negative, and HR-positive advanced breast cancer; coordination of trastuzumab, pertuzumab, T-DM1, T-DXd, pembrolizumab
- Breast plastic and reconstructive surgery — oncoplastic breast surgery with immediate reshaping; implant-based and autologous reconstruction after mastectomy
- Endoscopic breast surgery — laparoscopic and endoscopic minimally invasive breast tumor resection
- Thyroid cancer surgery (small incision) — precise thyroid cancer resection through minimally invasive small incisions; emphasis on cosmetic outcomes and rapid recovery
- Thyroid ablation surgery — radiofrequency ablation (RFA) and microwave ablation (MWA) for selected benign thyroid nodules and low-risk thyroid microcarcinomas; non-surgical alternative for eligible patients
- Cervical lymph node dissection — central and lateral neck dissection for thyroid cancer with lymph node metastases
Why Prof. Li Hengyu?
Prof. Li's 20+ years of focused thyroid and breast surgical experience, combined with his active involvement in CSCO and CMA guideline development, positions him as one of Shanghai's most comprehensively qualified surgeons in this specialty. His expertise spans the full treatment spectrum — from minimally invasive ablation for low-risk thyroid nodules to systemic targeted and immunotherapy coordination for advanced breast cancer.
His particular expertise in thyroid ablation is a differentiating capability. Radiofrequency and microwave ablation offers a non-surgical alternative that avoids general anesthesia, hospitalization, and surgical scarring — an increasingly popular option for patients who prefer to avoid surgery for low-risk lesions. Prof. Li's combined ablation and surgical expertise allows him to provide individualized guidance on the most appropriate approach for each patient.
His invitation to perform live surgical demonstrations and his role as a surgical skills competition judge are independent validations of his technical precision.
Hospital: Changhai Hospital, Naval Medical University
Changhai Hospital is one of Shanghai's major academic medical centers, with particular strengths in gastroenterology, oncology, and surgery. As a military-affiliated academic hospital, it combines rigorous clinical standards with strong research infrastructure. The Department of Thyroid and Breast Surgery — directed by Prof. Li — offers a comprehensive range of surgical and non-surgical treatment options, including thyroid ablation capabilities not universally available at all centers.
About Thyroid Ablation
- Radiofrequency ablation (RFA) and microwave ablation (MWA): image-guided thermal ablation performed under local anesthesia as an outpatient procedure; no surgical incision, no general anesthesia, same-day discharge
- Indications: benign thyroid nodules causing symptoms or cosmetic concerns; selected low-risk papillary thyroid microcarcinomas (≤1 cm) in patients who decline or are unfit for surgery
- Efficacy: volume reduction of 50–90% at 12 months for benign nodules; local tumor control rates >95% at 5 years for low-risk microcarcinomas in experienced hands
- Limitations: not appropriate for tumors >1 cm, multifocal disease, lymph node metastases, or aggressive histological subtypes
What to Prepare Before Your Consultation
For breast concerns:
- Mammogram and breast ultrasound reports with BI-RADS scoring
- Breast MRI if available
- Core biopsy pathology report with hormone receptor status (ER, PR, HER2, Ki-67)
- BRCA1/2 genetic testing results if available
- Complete prior treatment history for advanced breast cancer patients
For thyroid concerns:
- Neck ultrasound report with TI-RADS scoring and nodule measurements
- FNA cytology report (Bethesda classification) if biopsy has been performed
- Thyroid function tests: TSH, free T4, free T3
- CT scan of the neck if locally advanced disease is suspected
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) coordinates access to Prof. Li Hengyu and the Changhai Hospital Thyroid and Breast Surgery team for international patients. Our services include remote case review, priority appointment scheduling, full document translation, in-hospital accompaniment, and post-discharge follow-up.
Contact us to begin your case review:
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 Kommentare